Associate Director, Regulatory Affairs CMC

Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, which may be a promising option for patients with cancer. Overview The Associate Director, Regulatory CMC works collaboratively within the CMC regulatory and technical operation teams on writing projects for early, late-stage development, and commercial programs. They contribute to the drafting, reviewing and finalization of CMC content and/ or regulatory related documents. The individual also apply writing/editorial expertise to the development of CMC/Quality (Module 3) sections for filing and maintenance of initial INDs, initial CTAs (IMPDs), FDA BLA, EMA MAA, ROW submissions as well as CMC source documents. This position works closely with stakeholders to support corporate and departmental objectives. An important aspect of this role is the planning and management of writing projects. Attention to detail in their work and ability to collaborate with diverse internal and external stakeholders are both important factors for success in this role. Essential Functions and Responsibilities Works closely with functional leaders to 1) create the optimal development path for Iovance product candidates, 2) negotiate optimal development paths within internal cross-functional teams and with health authorities, 3) execute clinical-regulatory development plans on-time and while managing all identified risks. Collaborates with RA CMC Product Lead to execute CMC Submission and Authoring strategy for assigned project. Ensures that submission documents and correspondence are of the highest quality in terms of content, organization, clarity of writing, and accuracy. Ensures that evolving global regulations, guidelines and health authority expectations, especially those related to cell therapies, are incorporated into program decision making. Ensures writing activities meet quality standards and expectations and adhere to applicable Corporate SOPs, policies, guidelines, and regulation. Assures that standardized practices are implemented and maintained across regulatory documents. Collaborates with Regulatory Operations to ensure timely and accurate submissions Critically review source documents for consistency, completeness, and quality. Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics Perform miscellaneous duties as assigned. Required Education, Skills, and Knowledge Minimum of a BA/BS in Life Science 5-8 years pharmaceutical/biotechnology experience related to analytical/pharmaceutical chemistry and/or regulatory affairs. Demonstrated expertise in writing/developing CMC content in Briefing Documents, Quality Amendments, Module 2 and Module 3 updates and CMC source documents in support of US and global regulatory submissions (with primary interest in the areas of Biologic and Cell Therapy Products). Understanding of biological lifecycle drug development Experience with ICH, CTD and electronic submission guidelines for regulatory reports. Excellent written and verbal skills Ability to collaborate with a wide variety of internal customers and relate effectively to people at all levels of the organization Excellent computer skills including MS Office (Word, Excel, Power Point, Outlook); experience with electronic document management systems and other content authoring technologies (e.g. Veeva Vault) Analytical thinker with excellent problem-solving skills and the ability to adapt to changing priorities and deadlines. Proven track record with project mana ... (truncated, view full listing at source)